Additionally, Synpac, the drug company supporting the trials, was geared toward small experimental production volumes, with quite limited production capacity. When the time came to expand clinical trials and begin mass production, it had a hard time meeting requirements.
再加上贊助藥廠以小規模實驗型的生產模式，產量十分有限，到了要擴大臨床實驗及大規模量產時，就難以應付。